Cell-based cancer therapies, such as chimeric antigen receptor (CAR) T cell therapy, show promise in the clinic, especially against blood-based tumors. However, researchers continue to enhance treatment efficacy in blood and solid tumors and to tailor therapeutics to patients with unique needs. A range of single cell and spatial technologies helps scientists discover new drug targets, characterize cell-based infusions, monitor therapy response in patients over time, and identify factors contributing to treatment resistance.
Download this brochure from 10x Genomics to learn how to use high-throughput single cell gene expression, single cell immune profiling, and multiomic and spatial analyses to study and optimize cell-based cancer therapeutics.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.